Plain-English translation of NCT07205263 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The RAINBOW-ICH trial is testing a new approach to treating brain bleeding using AI-assisted robotic-guided surgery, which aims to remove blood from the brain with greater precision and less surgical damage than traditional methods. This trial enrolls 1,000 patients across multiple centers and compares the new robotic approach to standard surgical care, depending on the type and location of the brain bleeding. Doctors hope this treatment will reduce complications, speed recovery, and improve long-term outcomes for stroke patients.
Brain bleeding is a serious type of stroke that causes death and long-term disability in many patients worldwide. Current surgical treatments—such as traditional open brain surgery or standard drainage procedures—can cause significant injury and don't work equally well for all patients. This trial exists to see if advanced robotic technology guided by artificial intelligence can perform these delicate procedures more safely and effectively.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be randomly assigned to either receive AI-assisted robotic-guided minimally invasive surgery or standard surgical care (such as traditional brain surgery or medical management). The trial involves multiple hospital visits for surgery, imaging, and follow-up assessments to monitor your recovery and outcomes. You will be followed by the research team to track how well the treatment works and your overall health and functioning over time.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
China